Non-invasive approaches for the diagnosis of acute cardiac allograft rejection

Heart

Volumn 99, Issue 7, 2013, Pages 445-453

  Miller, Christopher A ^a,b   Fildes, James E ^a,b   Ray, Simon G ^a,b   Doran, Helen ^a   Yonan, Nizar ^a,b   Williams, Simon G ^a,b   Schmitt, Matthias ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD30 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; TROPONIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ACUTE CARDIAC GRAFT REJECTION; ARTICLE; BIOLUMINESCENCE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EARLY INTERVENTION; ECHOCARDIOGRAPHY; GENE EXPRESSION PROFILING; GOLD STANDARD; GRAFT RECIPIENT; HEART ELECTROPHYSIOLOGY; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; MOLECULAR IMAGING; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; NONHUMAN; PATIENT MONITORING; PATIENT SAFETY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DOPPLER IMAGING;

BIOLOGICAL MARKERS; BIOPSY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875223942     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302759     Document Type: Article

References (83)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: Twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010;29:1089-103.
2. Shoskes DA, Wood KJ. Indirect presentation of mhc antigens in transplantation. Immunol Today 1994;15:32-8.
3. Benichou G. Direct and indirect antigen recognition: The pathways to allograft immune rejection. Front Biosci 1999;4:D476-80.
4. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045. (Pubitemid 24140436)
5. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-20. (Pubitemid 41641841)
6. Kfoury AG, Hammond ME, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant 2009;28:781-4.
7. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009;28:417-22.
8. Berry GJ, Angelini A, Burke MM, et al. The ishlt working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 2011;30:601-11.
9. Subherwal S, Kobashigawa JA, Cogert G, et al. Incidence of acute cellular rejection and non-cellular rejection in cardiac transplantation. Transplant Proc 2004;36:3171-2. (Pubitemid 41126767)
10. Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: Differences in complication rate and diagnostic performance. Circulation 2010;122:900-9.
11. Baraldi-Junkins C, Levin HR, Kasper EK, et al. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 1993;12:63-7. (Pubitemid 23099861)
12. Dandel M, Hummel M, Meyer R, et al. Left ventricular dysfunction during cardiac allograft rejection: Early diagnosis, relationship to the histological severity grade, and therapeutic implications. Transplant Proc 2002;34:2169-73. (Pubitemid 35299704)
13. Sun JP, Abdalla IA, Asher CR, et al. Non-invasive evaluation of orthotopic heart transplant rejection by echocardiography. J Heart Lung Transplant 2005;24:160-5. (Pubitemid 40215591)
14. Almenar L, Osa A, Martinez-Dolz L, et al. Echocardiographic evaluation of the evolutionary changes after heart transplantation. Transplant Proc 2006;38:2575-6. (Pubitemid 44693691)
15. Mena C, Wencker D, Krumholz HM, et al. Detection of heart transplant rejection in adults by echocardiographic diastolic indices: a systematic review of the literature. J Am Soc Echocardiogr 2006;19:1295-300. (Pubitemid 44430139)
16. Stengel SM, Allemann Y, Zimmerli M, et al. Doppler tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection. Heart 2001;86:432-7. (Pubitemid 32889382)
17. Palka P, Lange A, Galbraith A, et al. The role of left and right ventricular early diastolic doppler tissue echocardiographic indices in the evaluation of acute rejection in orthotopic heart transplant. J Am Soc Echocardiogr 2005;18:107-15. (Pubitemid 40170037)
18. Leonard GT Jr., Fricker FJ, Pruett D, et al. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients. J Heart Lung Transplant 2006;25:61-6. (Pubitemid 43049666)
19. Prakash A, Printz BF, Lamour JM, et al. Myocardial performance index in pediatric patients after cardiac transplantation. J Am Soc Echocardiogr 2004;17:439-42. (Pubitemid 38881100)
20. Dandel M, Hummel M, Muller J, et al. Reliability of tissue doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations. Circulation 2001;104: I184-91. (Pubitemid 32884800)
21. Mankad S, Murali S, Kormos RL, et al. Evaluation of the potential role of color-coded tissue doppler echocardiography in the detection of allograft rejection in heart transplant recipients. Am Heart J 1999;138:721-30. (Pubitemid 29471048)
22. Puleo JA, Aranda JM, Weston MW, et al. Noninvasive detection of allograft rejection in heart transplant recipients by use of doppler tissue imaging. J Heart Lung Transplant 1998;17:176-84. (Pubitemid 28103528)
23. Dandel M, Lehmkuhl H, Knosalla C, et al. Strain and strain rate imaging by echocardiography-basic concepts and clinical applicability. Curr Cardiol Rev 2009;5:133-48.
24. Fabregas RI, Crespo-Leiro MG, Muniz J, et al. Usefulness of pulsed doppler tissue imaging for noninvasive detection of cardiac rejection after heart transplantation. Transplant Proc 1999;31:2545-7. (Pubitemid 29434043)
25. Marciniak A, Eroglu E, Marciniak M, et al. The potential clinical role of ultrasonic strain and strain rate imaging in diagnosing acute rejection after heart transplantation. Eur J Echocardiogr 2007;8:213-21. (Pubitemid 46657224)
26. Kato TS, Oda N, Hashimura K, et al. Strain rate imaging would predict sub-clinical acute rejection in heart transplant recipients. Eur J Cardiothorac Surg 2010;37:1104-10.
27. Roshanali F, Mandegar MH, Bagheri J, et al. Echo rejection score: New echocardiographic approach to diagnosis of heart transplant rejection. Eur J Cardiothorac Surg 2010;38:176-80.
28. Sato T, Kato TS, Kamamura K, et al. Utility of left ventricular systolic torsion derived from 2-dimensional speckle-tracking echocardiography in monitoring acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011;30:536-43.
29. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to crt (prospect) trial. Circulation 2008;117:2608-16.
30. Sade LE, Sezgin A, Ulucam M, et al. Evaluation of the potential role of echocardiography in the detection of allograft rejection in heart transplant recipients. Transplant Proc 2006;38:636-8.
31. Pieper GM, Shah A, Harmann L, et al. Speckle-tracking 2-dimensional strain echocardiography: a new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation. J Heart Lung Transplant 2010;29:1039-46.
32. Eleid MF, Caracciolo G, Cho EJ, et al. Natural history of left ventricular mechanics in transplanted hearts: Relationships with clinical variables and genetic expression profiles of allograft rejection. JACC Cardiovasc Imaging 2010;3:989-1000.
33. Hansen DE, Daughters GT II, Alderman EL, et al. Effect of acute human cardiac allograft rejection on left ventricular systolic torsion and diastolic recoil measured by intramyocardial markers. Circulation 1987;76:998-1008. (Pubitemid 17157280)
34. Yun KL, Niczyporuk MA, Daughters GT II, et al. Alterations in left ventricular diastolic twist mechanics during acute human cardiac allograft rejection. Circulation 1991;83:962-73.
35. Angermann CE, Nassau K, Stempfle HU, et al. Recognition of acute cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients. Comparison with conventional echocardiography. Circulation 1997;95:140-50. (Pubitemid 27029955)
36. Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52:184-8. (Pubitemid 13061350)
37. Sasaguri S, LaRaia PJ, Fabri BM, et al. Early detection of cardiac allograft rejection with proton nuclear magnetic resonance. Circulation 1985;72:II231-6.
38. Aherne T, Tscholakoff D, Finkbeiner W, et al. Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 1986;74:145-56. (Pubitemid 16092935)
39. Marie PY, Angioi M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial t2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825-31. (Pubitemid 32202451)
40. Wisenberg G, Pflugfelder PW, Kostuk WJ, et al. Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. Am J Cardiol 1987;60:130-6. (Pubitemid 17125662)
41. Taylor AJ, Vaddadi G, Pfluger H, et al. Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection. Eur J Heart Fail 2010;12:45-51.
42. Steen H, Merten C, Refle S, et al. Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol 2008;52:1160-7.
43. Rivard AL, Swingen CM, Blake D, et al. A comparison of myocardial perfusion and rejection in cardiac transplant patients. Int J Cardiovasc Imaging 2007;23:575-82.
44. Muehling OM, Wilke NM, Panse P, et al. Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003;42:1054-60. (Pubitemid 37108593)
45. Nitenberg A, Tavolaro O, Loisance D, et al. Maximal coronary vasodilator capacity of orthotopic heart transplants in patients with and without rejection. Am J Cardiol 1989;64:513-8. (Pubitemid 19214583)
46. Wu YL, Ye Q, Foley LM, et al. In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular mri. Proc Natl Acad Sci U S A 2006;103:1852-7. (Pubitemid 43228782)
47. Wu YL, Ye Q, Sato K, et al. Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. JACC Cardiovasc Imaging 2009;2:731-41.
48. Kanno S, Wu YJ, Lee PC, et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001;104:934-8. (Pubitemid 32778046)
49. Johansson L, Johnsson C, Penno E, et al. Acute cardiac transplant rejection: detection and grading with mr imaging with a blood pool contrast agent-experimental study in the rat. Radiology 2002;225:97-103.
50. Penno E, Johnsson C, Johansson L, et al. Comparison of ultrasmall superparamagnetic iron oxide particles and low molecular weight contrast agents to detect rejecting transplanted hearts with magnetic resonance imaging. Invest Radiol 2005;40:648-54. (Pubitemid 41384054)
51. Penno E, Johansson L, Ahlstrom H, et al. Ultrasmall iron oxide particle contrast agent and MRI can be used to monitor the effect of anti-rejection treatment. Transplantation 2007;84:374-9. (Pubitemid 47258326)
52. Bernd H, De Kerviler E, Gaillard S, et al. Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program. Invest Radiol 2009;44:336-42.
53. Frist W, Yasuda T, Segall G, et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (fab) imaging. Circulation 1987;76: V81-5.
54. Hesse B, Mortensen SA, Folke M, et al. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation. J Heart Lung Transplant 1995;14:23-31.
55. Narula J, Acio ER, Narula N, et al. Annexin-v imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001;7:1347-52. (Pubitemid 34007940)
56. Kown MH, Strauss HW, Blankenberg FG, et al. In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin v. Am J Transplant 2001;1:270-7. (Pubitemid 33674171)
57. Eisen HJ, Eisenberg SB, Saffitz JE, et al. Noninvasive detection of rejection of transplanted hearts with indium-111-labeled lymphocytes. Circulation 1987;75:868-76. (Pubitemid 17052672)
58. Rubin PJ, Hartman JJ, Hasapes JP, et al. Detection of cardiac transplant rejection with 111in-labeled lymphocytes and gamma scintigraphy. Circulation 1996;94: II298-303. (Pubitemid 26363410)
59. Gierthmuehlen M, Sommer P, Zuhayra M, et al. Imaging of acute heart-transplant rejection using 99m-technetium labelled oligonucleotides against interleukin-2 mrna in rats. Eur J Cardiothorac Surg 2010;37:1111-6.
60. Tanaka M, Swijnenburg RJ, Gunawan F, et al. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 2005;112:I105-10. (Pubitemid 41266660)
61. Christen T, Nahrendorf M, Wildgruber M, et al. Molecular imaging of innate immune cell function in transplant rejection. Circulation 2009;119:1925-32.
62. Weller GE, Lu E, Csikari MM, et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 2003;108:218-24. (Pubitemid 36871306)
63. Keren A, Gillis AM, Freedman RA, et al. Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine. Circulation 1984;70:I124-9.
64. Cooper DK, Charles RG, Rose AG, et al. Does the electrocardiogram detect early acute heart rejection. J Heart Transplant 1985;4:546-9. (Pubitemid 16086074)
65. Eckart RE, Kolasa MW, Khan NA, et al. Surface electrocardiography and histologic rejection following orthotopic heart transplantation. Ann Noninvasive Electrocardiol 2005;10:60-4. (Pubitemid 40476668)
66. Kertesz NJ, Towbin JA, Clunie S, et al. Long-term follow-up of arrhythmias in pediatric orthotopic heart transplant recipients: Incidence and correlation with rejection. J Heart Lung Transplant 2003;22:889-93. (Pubitemid 36945487)
67. Graceffo MA, O'Rourke RA. Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram. Am Heart J 1996;132:820-6. (Pubitemid 26366982)
68. Lacroix D, Kacet S, Savard P, et al. Signal-averaged electrocardiography and detection of heart transplant rejection: comparison of time and frequency domain analyses. J Am Coll Cardiol 1992;19:553-8.
69. Horenstein MS, Idriss SF, Hamilton RM, et al. Efficacy of signal-averaged electrocardiography in the young orthotopic heart transplant patient to detect allograft rejection. Pediatr Cardiol 2006;27:589-93. (Pubitemid 44496583)
70. Morocutti G, Di Chiara A, Proclemer A, et al. Signal-averaged electrocardiography and doppler echocardiographic study in predicting acute rejection in heart transplantation. J Heart Lung Transplant 1995;14:1065-72. (Pubitemid 26008638)
71. Bourge R, Eisen H, Hershberger R, et al. Noninvasive rejection monitoring of cardiac transplants using high resolution intramyocardial electrograms: Initial us multicenter experience. Pacing Clin Electrophysiol 1998;21:2338-44.
72. Grasser B, Iberer F, Schreier G, et al. Computerized heart allograft-recipient monitoring: a multicenter study. Transpl Int 2003;16:225-30. (Pubitemid 36682179)
73. Grasser B, Iberer F, Schreier G, et al. Intramyocardial electrogram variability in the monitoring of graft rejection after heart transplantation. Pacing Clin Electrophysiol 1998;21:2345-9.
74. Garrido IP, Pascual-Figal DA, Nicolas F, et al. Usefulness of serial monitoring of b-type natriuretic peptide for the detection of acute rejection after heart transplantation. Am J Cardiol 2009;103:1149-53.
75. Chance JJ, Segal JB, Wallerson G, et al. Cardiac troponin t and c-reactive protein as markers of acute cardiac allograft rejection. Clin Chim Acta 2001;312:31-9. (Pubitemid 32913578)
76. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004;110:3815-21. (Pubitemid 40028320)
77. Schoels M, Dengler TJ, Richter R, et al. Detection of cardiac allograft rejection by real-time pcr analysis of circulating mononuclear cells. Clin Transplant 2004;18:513-7. (Pubitemid 39264346)
78. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006;6:150-60. (Pubitemid 43382213)
79. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010;362:1890-900.
80. White JA, Guiraudon C, Pflugfelder PW, et al. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 1995;14:1052-6. (Pubitemid 26008636)
81. Costanzo MR, Dipchand A, Starling R, et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-56.
82. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast t1 and t2 cmr delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603.
83. Richards JM, Semple SI, MacGillivray TJ, et al. Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: A pilot study. Circ Cardiovasc Imaging 2011;4:274-81.